Invacare Corporation  

(Public, NYSE:IVC)   Watch this stock  
Find more results for IVC
14.93
+0.12 (0.84%)
Real-time:   2:41PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 14.71 - 15.00
52 week 8.00 - 16.65
Open 14.80
Vol / Avg. 46,375.00/344,376.00
Mkt cap 494.30M
P/E     -
Div/yield 0.01/0.34
EPS -1.58
Shares 32.04M
Beta 2.12
Inst. own 108%
Jul 26, 2017
Q2 2017 Invacare Corp Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 6, 2017
Invacare Corp at Jefferies Healthcare Conference Add to calendar
May 18, 2017
Invacare Corp Annual Shareholders Meeting
May 9, 2017
Q1 2017 Invacare Corp Earnings Call - Webcast
May 8, 2017
Q1 2017 Invacare Corp Earnings Release
Apr 4, 2017
Invacare Corp at 16th Annual Needham Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin -7.24% -4.09%
Operating margin -6.12% -2.82%
EBITD margin - -0.51%
Return on average assets -7.59% -4.92%
Return on average equity -16.23% -9.68%
Employees 4,600 -
CDP Score - -

Address

1 Invacare Way PO Box 4028
ELYRIA, OH 44036-2028
United States - Map
+1-440-3296000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

Officers and directors

Matthew E. Monaghan Chairman of the Board, President, Chief Executive Officer
Age: 49
Bio & Compensation  - Reuters
Robert K. Gudbranson Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Anthony C. LaPlaca Senior Vice President, General Counsel, Secretary
Age: 1
Bio & Compensation  - Reuters
Ralf Ledda Senior Vice President, General Manager - Europe, Middle East and Africa
Bio & Compensation  - Reuters
Patricia A. Stumpp Senior Vice President - Human Resources
Age: 53
Bio & Compensation  - Reuters
C. Martin Harris M.D. Lead Independent Director
Age: 60
Bio & Compensation  - Reuters
Susan H. Alexander Esq. Director
Age: 60
Bio & Compensation  - Reuters
Clifford D. Nastas Director
Age: 51
Bio & Compensation  - Reuters
Marc M. Gibeley Independent Director
Age: 51
Bio & Compensation  - Reuters
Dale C. LaPorte Independent Director
Age: 73
Bio & Compensation  - Reuters